Table 2.
Lesion characteristics regarding FDG uptake of training cohort
| P1, n=35 | P0, n=47 | p | |
|---|---|---|---|
| Lesion-to-liver ratio | |||
| SUVmax | 2.22 (1.82, 3.21) | 1.16±0.22 | < 0.001* |
| SUVmean | 1.73 (1.39, 2.23) | 0.91 (0.84, 1.08) | < 0.001* |
| Lesion-to-blood pool ratio | |||
| SUVmax | 4.10 (3.47, 6.94) | 1.94±0.48 | < 0.001* |
| SUVmean | 1.73 (1.39, 2.23) | 1.53 (1.35, 1.81) | 0.108 |
| MTV (cm3) | 6.62 (2.84, 32.49) | 17.07 (8.01, 27.83) | 0.095 |
| TLG (cm3) | 43.98 (14.27, 173.22) | 47.13 (20.88, 83.09) | 0.591 |
Normally distributed continuous variables are presented as the mean ± standard deviation, while non-normally distributed data are presented as the median (IQR, interquartile range)
P1 patients with prominent HCC lesions visually, P0 patients with non-prominent HCC lesions visually, MTV metabolic tumor volume, TLG total lesion glycolysis
*p < 0.05 and the symbol [italics] were considered significant